Stocktoria
INCYTE CORP INCY
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 1993-12-06
INCYTE CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 29.5% | 1.4% | 16.8% | 17.1% | 19.6% |
| Net margin | 25.0% | 0.8% | 16.2% | 10.0% | 31.8% |
| Return on assets | 18.5% | 0.6% | 8.8% | 5.8% | 19.2% |
| Return on equity | 24.9% | 0.9% | 11.5% | 7.8% | 25.2% |
| Current ratio | 3.32 | 1.97 | 3.75 | 3.54 | 3.65 |
| Revenue growth | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% |
Source: SEC EDGAR filings · CIK 0000879169 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.